Search
Close this search box.
Search
[custom_company_search_form]
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)

Stock Piper AI Index

Subscribe
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)

Island Pharmaceuticals Ltd

ILA

ASX

Island Pharmaceuticals Limited (ILA) is a mid-clinical stage biotechnology company and drug repurposing company, focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Company's lead asset is ISLA-101, a drug with a well- established safety profile, being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases.

Latest Posts

Line Chart with Gradient
Price
$0.08
0 (0%)
At Close 20/09 (AEST)
Related Companies
RECCE PHARMACEUTICALS LTD
$RCE
PROBIOTEC LIMITED
$PBP
CANN GROUP LIMITED
$CAN
VECTUS BIOSYSTEMS LIMITED
$VBS
AUSCANN GROUP HOLDINGS LTD
$AC8

Latest Posts

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) reports positive data from ISLA-101 study

Reconfirms strong safety and pharmacokinetic data for Phase 2a clinical trial in dengue fever

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) progresses ISLA-101 phase 2a/b clinical trial

Progress update on PROTECT Phase 2a/b study for dengue fever treatment

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) signs non-binding term sheet with BioCryst

Acquires antiviral molecule galidesivir to diversify pipeline

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) reinstates options to quotation

Options of ILA reinstated to quotation by ASX Compliance

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) announces rights issue to raise $1.95 million

Capital raising to advance ISLA-101 for dengue fever treatment

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) offers non-renounceable pro rata shares and options

Aims to raise $1.95 million for clinical trials, IP, and business development

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) progresses ISLA-101 Single Ascending Dose study

Company advances ISLA-101 study for dengue fever prevention

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) progresses ISLA-101 study and secures key patent

Completes dosing cohorts, secures patent, and secures R&D Tax Incentive prepayment

ILA

$ILA

Island Pharmaceuticals (ASX: $ILA) doses third cohort in ISLA-101 study

Third cohort dosed under fasted conditions, on track to report trial data in early 2024

Related Companies
MAYNE PHARMA GROUP LIMITED
$MYX
ANATARA LIFESCIENCES LTD
$ANR
EPSILON HEALTHCARE LIMITED
$EPN
AUSCANN GROUP HOLDINGS LTD
$AC8
PACIFIC EDGE LIMITED
$PEB

ASX News, First
& Fast.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

By clicking Subscribe, you agree to our Terms & Conditions

© 2024 Stock Piper. All rights reserved

© 2024 Stock Piper.
All rights reserved

Blog

Healthcare
Materials
Real Estate
Consumer Staples
Consumer Discretionary Brief
Utilities

Company

About us
Terms of use
Privacy Policy

Support

Request Form
Contact Support
FAQ
Glossary

Socials

Facebook
Twitter
LinkedIn
© 2024 Stock Piper. All rights reserved
Social Media Auto Publish Powered By : XYZScripts.com
Join FREE Newsletter

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions